Mindfulness Therapy for Insomnia
(Project WISHES Trial)

Recruiting in Palo Alto (17 mi)

Overseen bySoohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Yale University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.

Research Team

Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN

Principal Investigator

Yale University School of Nursing

Eligibility Criteria

This trial is for Black women who are experiencing insomnia and may have cardiometabolic syndrome, which includes conditions like heart disease and diabetes. Participants should be interested in trying a mindfulness-based therapy to improve their sleep.

Inclusion Criteria

English speaking

I am a Black woman.

Additional quantitative insomnia criteria based on research recommendations and the new ICSD3: (a) severity of sleep onset latency or wake time after sleep onset of ≥31 min, (b) occurring ≥3 nights a week, and (c) for ≥ 3 months.

See 1 more

Exclusion Criteria

Psychosis or unstable/significant depression, anxiety, or substance abuse under active care (more than 1 monthly mental healthcare visit or requiring more than 1 psychotropic medicine daily)

I meditate for more than 15 minutes daily.

I have sleep apnea, restless legs, or a condition affecting my sleep/wake cycle.

See 1 more

Treatment Details

Interventions

Mindfulness-based therapy for insomnia (MBTI) (Behavioral Intervention)

Trial OverviewThe study is testing Mindfulness-Based Therapy for Insomnia (MBTI), aiming to reduce stress and the risk of diseases related to poor sleep among participants by teaching them techniques to enhance their sleep quality.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: MBTIExperimental Treatment1 Intervention

Participants randomized to MBTI group.

Group II: ControlActive Control1 Intervention

Participants randomized to waitlist control group.